Lymphoma / Leukemia Program
Program Leader:
Elizabeth Bengtson, MD
The Lymphoma/Leukemia Program is a research-based program offering comprehensive cancer care to patients with lymphoid malignancies, including relapsed, refractory, and poor-prognosis disease. Using advanced and innovative treatment approaches, the Lymphoma/Leukemia Program provides state of the art patient-centered care. Our goal is to provide an integrated approach to treatment by collaborating closely with other care providers and the referring physician. Support groups and annual educational seminars are offered for patients and families.
Special Services and Diagnostic Tests
- A full complement of blood banking services for patients undergoing autologous and allogeneic transplantation
- Magnetic resonance, computer tomography and nuclear medicine imaging
- Cytogenetics
- Molecular diagnostic tests
- Flow cytometry
- Specialized immunologic tissue staining and cytology
Research Interests
- Novel immunologic and pharmacologic strategies to eliminate minimal residual disease following tumor-reductive therapy
- Psychosocial aspects of lymphoma and its treatment
- Administration of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for relapsed or poor-prognosis disease
- Collaboration with our Allogeneic Bone Marrow Transplant program in appropriate cases
